You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Cost-effectiveness of enzyme replacement therapy for type 1 Gaucher disease
|
|---|---|
| Published in |
Orphanet Journal of Rare Diseases, April 2014
|
| DOI | 10.1186/1750-1172-9-51 |
| Pubmed ID | |
| Authors |
Laura van Dussen, Marieke Biegstraaten, Carla EM Hollak, Marcel GW Dijkgraaf |
| Abstract |
To evaluate the cost-effectiveness of enzyme replacement therapy (ERT) compared to standard medical care without ERT in the Dutch cohort of patients with type 1 Gaucher disease (GD I). |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Scientists | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 93 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 19 | 20% |
| Student > Ph. D. Student | 11 | 12% |
| Student > Master | 11 | 12% |
| Student > Bachelor | 8 | 9% |
| Student > Doctoral Student | 5 | 5% |
| Other | 19 | 20% |
| Unknown | 20 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 17% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 15% |
| Biochemistry, Genetics and Molecular Biology | 11 | 12% |
| Economics, Econometrics and Finance | 8 | 9% |
| Agricultural and Biological Sciences | 6 | 6% |
| Other | 17 | 18% |
| Unknown | 21 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 December 2019.
All research outputs
#3,129,062
of 24,878,531 outputs
Outputs from Orphanet Journal of Rare Diseases
#435
of 2,991 outputs
Outputs of similar age
#30,399
of 232,491 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#2
of 27 outputs
Altmetric has tracked 24,878,531 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,991 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 232,491 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.